FundRx
FundRx is a privately held New York City-based venture capital firm founded in 2015, focused exclusively on early-stage healthcare and life science investments with a team of 11-50 employees.
- Company typePrivate
- Founded2021
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What FundRx does
FundRx is a privately held venture capital firm headquartered in New York City and founded in 2015. The firm self-describes as "the next-generation of healthcare and life science venture capital," indicating a vertical specialization in healthcare and life science investments rather than a generalist strategy. With a team of 11-50 employees, FundRx operates as a small, focused investment organization rather than a large multi-strategy platform.
As a venture capital firm, FundRx's business model follows the standard VC economics: it raises capital from limited partners, deploys that capital into portfolio companies, and earns revenue through management fees on assets under management plus potential carried interest on realized gains. The firm maintains a public web presence at fundrx.com. Detailed information about FundRx's specific portfolio companies, fund vintages, AUM, fee structure, investment stage focus (seed, Series A, etc.), check sizes, co-investor network, recent financings, leadership team, and geographic footprint beyond its New York headquarters is not disclosed in the provided source material.
The available data is limited to high-level firmographics. No information is provided regarding FundRx's technology infrastructure, AI/ML usage in deal sourcing or diligence, partnerships, awards, regulatory filings, leadership changes, product launches, M&A activity, or revenue figures. This data gap materially constrains any deeper strategic, financial, or competitive analysis of the firm.
FundRx firmographics
Firmographics- Name
- FundRx
- Legal name
- MBX Capital, LLC
- Website
- https://fundrx.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- FundRx is a privately held New York City-based venture capital firm founded in 2015, focused exclusively on early-stage healthcare and life science investments with a team of 11-50 employees.
- Ownership category
- akta.pro rank
FundRx industry classification
Industry- Product category
- Healthcare Venture Capital
- NAICS
- Funds, Trusts, and Other Financial Vehicles (525)
- akta.pro primary industry
- Venture Debt Providers (FSANAAAL)
Keywords
Where FundRx is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Markets served
FundRx business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
FundRx product offering
Product offeringCore offering
FundRx is a venture capital firm focused on providing early-stage capital and partnership to healthcare and life science companies. The firm positions itself as the next-generation of healthcare and life science venture capital, investing in visionary founders working on deep health innovations across areas such as AI-driven drug discovery, genomics, mental health, maternal health, dental healthcare, and medical technology. Detailed information on specific FundRx investment vehicles, fund size, or portfolio composition is not available in the provided source material.
Differentiator
Problem solved
Functional benefit
Companies that use FundRx
Customer profileIdeal customer profiles1 record
FundRx technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
FundRx competitors and assessment
Company assessmentDirect peers
- ARCH Venture Partners: Early-stage venture firm investing in science-driven healthcare and technology companies, with a comparable thesis of backing deep-tech and biotech founders at inception — overlaps directly with MBX's deep-health orientation.
- Lux Capital: Frontier science and technology VC with significant health/biotech exposure; matches MBX's stage, founder-led approach, and willingness to underwrite technical risk early.
- Civilization Ventures: Early-stage firm investing in health, biotech, and biology-led platforms — directly comparable thesis focus on transformative healthcare at seed/Series A.
- Section32: Venture fund investing in early-stage health technology and biotech companies; overlaps with MBX on stage, healthcare mandate, and operator-led diligence approach.
- ARTIS Ventures: Early-stage VC funding pioneering science and technology founders including life sciences; comparable stage focus and willingness to back deep-tech health bets ahead of validation.
- Santé Ventures: Early-stage healthcare and life sciences venture firm; same sector mandate and early-stage orientation as MBX Capital's deep-health thesis.
Broad incumbents
- Andreessen Horowitz (a16z Bio): Major multi-stage tech VC with a dedicated Bio fund investing across healthcare and life sciences; co-invests with MBX in companies like Earli — broader scale and stage, overlapping healthcare focus.
- Khosla Ventures: Large venture firm with a deep healthcare and biotech practice; recurring co-investor across MBX portfolio (Vivodyne, Earli, Eva Tech) with broadly overlapping thesis.
- Flagship Pioneering: Healthcare-specific platform that creates and funds biotech companies at scale; broader remit and far larger AUM, but mirrors MBX's deep-health origination model.
- Founders Fund: Multi-stage tech VC with biotech/healthcare exposure; co-invests with MBX (e.g., Fathom Health) — broader portfolio mandate with thematic overlap in frontier health.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat1 record
Key risks6 records
Key highlights6 records
Customer concentration
FundRx social profiles
Digital presenceFundRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
FundRx leadership team
Management profileNumber of profiles
FundRx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FundRx M&A and investment
M&A and investmentM&A
Investments10 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FundRx
What does FundRx do?
FundRx is a venture capital firm focused on providing early-stage capital and partnership to healthcare and life science companies. The firm positions itself as the next-generation of healthcare and life science venture capital, investing in visionary founders working on deep health innovations across areas such as AI-driven drug discovery, genomics, mental health, maternal health, dental healthcare, and medical technology. Detailed information on specific FundRx investment vehicles, fund size, or portfolio composition is not available in the provided source material.
Is FundRx a public or private company?
FundRx is a private company. It is classified as unknown and is currently operating.
When was FundRx founded?
FundRx was founded in 2021. It employs 11 to 50 people.
Where is FundRx based?
FundRx is headquartered in New York, United States, in the North America region.
Who are FundRx's main competitors?
Direct peers on record are ARCH Venture Partners, Lux Capital, Civilization Ventures, Section32, ARTIS Ventures and Santé Ventures. Broad incumbents are Andreessen Horowitz (a16z Bio), Khosla Ventures, Flagship Pioneering and Founders Fund.
Does FundRx have an API?
No public API is recorded for FundRx.
What industry is FundRx in?
FundRx's product category is Healthcare Venture Capital. Its primary akta.pro industry code is FSANAAAL, Venture Debt Providers. Its NAICS code is 525.